Pricing Log in Create free account

Gelteq Limited (GELS) vs Sonoma Pharmaceuticals, Inc. (SNOA)

Gelteq Limited and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $5.5M against $4.6M — 1.2× the size. Across the 9 metrics below, Gelteq Limited leads on 6 and Sonoma Pharmaceuticals, Inc. on 3.

Valuation

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S — 0.20 2.11
P/B n/m 0.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 0.70 12.58
EV/Sales n/m (0.04) 2.73
Earnings yield — (107.96%) (4.38%)
Free cash flow yield 0.00% (61.09%) 0.00%

Profitability

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Gross margin — 38.91% 53.94%
Operating margin — (6.41%) 0.00%
Net margin — (10.33%) 0.00%
Free cash flow margin 0.00% (12.11%) 0.00%
Return on equity 0.00% (42.52%) (0.40%)
Return on assets 0.00% (13.85%) (3.32%)
Return on invested capital 0.00% (69.96%) 0.00%

Growth

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 47.00% 10.01%
EPS growth (last fiscal year) (62.07%) 32.26% 49.06%
Revenue growth, 5-year CAGR — 0.95% 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.05
Current ratio 0.09 2.99 2.31
Net debt to EBITDA (0.91) 1.03 0.97

Dividend

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Market cap 4.61m 5.50m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack